Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis
Author
Chaddock, Natalie J MHarden, Charlotte J
Sorensen, Louise
Mathieson, Hannah R
Zulcinski, Michal
Lawson, Catherine A
O'Sullivan, Eoin
Mollan, Susan P
Martin, Javier
Mackie, Sarah L
Iles, Mark M
Morgan, Ann W
Affiliation
University of Leeds; Leeds Teaching Hospitals NHS Trust; Harrogate District Hospital; King's College Hospital NHS; University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; López-Neyra, IPBLN, CSIC, GranadaOther Contributors
Haroon Raashid, LubnaMartin, Steve
Robinson, James I
Publication date
2024-10-03
Metadata
Show full item recordAbstract
Objectives: This project aimed to determine whether cranial ischaemic complications at the presentation of giant cell arteritis (GCA) were associated with pre-existing cardiovascular (CV) risk factors, CV disease or genetic risk of CV-related traits. Methods: 1946 GCA patients with clinicodemographic data at GCA presentation were included. Associations between pre-existing CV-related traits (including Polygenic Risk Scores (PRS) for CV traits) and cranial ischaemic complications were tested. A model for cranial ischaemic complications was optimised using an elastic net approach. Positional gene mapping of associated PRS was performed to improve biological understanding. Results: In a sample of 1946 GCA patients (median age=71, 68.7% female), 17% had cranial ischaemic complications at presentation. In univariable analyses, 10 variables were associated with complications (likelihood-ratio test p≤0.05). In multivariable analysis, the two variables with the strongest effects, with or without PRS in the model, were anticoagulant therapy (adjusted OR (95% CI)=0.21 (0.05 to 0.62), p=4.95×10-3) and age (adjusted OR (95% CI)=1.60 (0.73 to 3.66), p=2.52×10-3, for ≥80 years versus <60 years). In sensitivity analyses omitting anticoagulant therapy from multivariable analysis, age and hypertension were associated with cranial ischaemic complications at presentation (hypertension: adjusted OR (95% CI)=1.35 (1.03 to 1.75), p=0.03). Positional gene mapping of an associated transient ischaemic attack PRS identified TEK, CD96 and MROH9 loci. Conclusion: Age and hypertension were risk factors for cranial ischaemic complications at GCA presentation, but in this dataset, anticoagulation appeared protective. Positional gene mapping suggested a role for immune and coagulation-related pathways in the pathogenesis of complications. Further studies are needed before implementation in clinical practice.Citation
Chaddock NJM, Harden CJ, Sorensen L, Mathieson HR, Zulcinski M, Lawson CA, O'Sullivan E, Mollan SP, Martin J, Mackie SL, Iles MM, Morgan AW; UK GCA Consortium. Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis. Ann Rheum Dis. 2024 Oct 3:ard-2024-225515. doi: 10.1136/ard-2024-225515. Epub ahead of print.Type
ArticleAdditional Links
https://ard.bmj.com/PMID
39362697Journal
Annals of the Rheumatic DiseasesPublisher
BMJ Publishing Groupae974a485f413a2113503eed53cd6c53
10.1136/ard-2024-225515